Biogen Inc.

NasdaqGS:BIIB

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 18.77 B

Share Price

USD 128.00

Avg Daily Volume

1,488,264

Change (1 day)

-2.04%

Change (1 year)

-36.63%

Change (YTD)

-16.30%

Biogen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending September 30, 2024: USD 629.30 M

Biogen Inc. Depreciation And Amortization is USD 629.30 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 32.62% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.

Biogen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 474.50 M, a -11.03% change year over year.
Biogen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 533.30 M, a 20.28% change year over year.
Biogen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 443.40 M, a -3.73% change year over year.
Biogen Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 460.60 M, a -48.67% change year over year.